Hahn H H, MacGregor R R, Avent C K, Counts G W, Smith H E, Beaty H N
Antimicrob Agents Chemother. 1972 Jul;2(1):45-8. doi: 10.1128/AAC.2.1.45.
Ampicillin and tetracycline, in doses of 2 g a day, were compared in the treatment of acute exacerbations of chronic bronchitis. Seventy-nine patients were followed for 3 to 29 months and were treated for 118 exacerbations. Clinical improvement occurred after 10 days of treatment with either drug in over 80% of the cases. Haemophilus influenzae and Diplococcus pneumoniae were eradicated from the sputum more than 60% of the time, but in general there was a poor correlation between bacteriological clearing and clinical response. The effect of chemoprophylaxis with ampicillin and tetracycline in doses of 1 g a day on the frequency of acute exacerbations of bronchitis was compared with that of a placebo. Seven hundred eighty prophylactic regimens, consisting of one capsule every 12 hr for 5 days beginning with the first sign of a cold, were prescribed for 76 patients. Irrespective of the regimen, an acute exacerbation of bronchitis was encountered at approximately 13% of the follow-up visits to the clinic.
对剂量为每日2克的氨苄西林和四环素治疗慢性支气管炎急性加重期的效果进行了比较。79例患者随访3至29个月,共治疗118次加重发作。两种药物治疗10天后,超过80%的病例出现临床改善。超过60%的时间里,痰液中的流感嗜血杆菌和肺炎双球菌被清除,但总体而言,细菌学清除与临床反应之间的相关性较差。将剂量为每日1克的氨苄西林和四环素的化学预防对支气管炎急性加重发作频率的影响与安慰剂进行了比较。对76例患者开出了780个预防方案,从感冒的第一个迹象开始,每12小时服用一粒胶囊,持续5天。无论采用何种方案,在诊所随访时约13%的患者出现了支气管炎急性加重发作。